Physician profile
James K Ware
NPI 1619090396
$8,840.77
in general payments reported to CMS, 2019-2025
9 companies · $30.29 in 2025
The $30.29 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $809 · 2021: $1,224 · 2022: $3,658 · 2023: $1,592 · 2024: $1,376 · 2025: $30.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,053 · Food and Beverage: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,053.37 |
| Food and Beverage | $943.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $5,888.48 | 2020-2024 | |
| Arthrex, INC. | $1,382.78 | 2023-2024 | |
| Medical Device Business Services, INC. | $1,033.03 | 2023 | Bristow Latarjet |
| Depuy Synthes Sales INC. | $350.88 | 2019-2024 | Vapr, Dynacord, Healix Knotless Peek |
| Amniox Medical, INC. | $102.50 | 2019 | |
| Biotronik Nro, INC. | $30.29 | 2025 | Prospera |
| Vericel Corporation | $22.20 | 2024 | Maci |
| Ferring Pharmaceuticals INC. | $16.11 | 2024 | Euflexxa |
| Kowa Pharmaceuticals America, INC. | $14.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ware listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.